Chester County News and Community Website
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has reported impressive financial results for its fiscal year 2024 fourth quarter, marking a 14.7% increase in revenue to $79.1 billion. The company …
Cencora Reports Strong Revenue Growth in Fourth Quarter, Announces Strategic Initiatives Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced a definitive agreement to acquire Retina Consultants of America (RCA) from Webster Equity Partners for approximately $4.6 billion. This move aims …
Cencora Announces Strategic Acquisition of Retina Consultants of America Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced the appointment of Francois Mandeville as Executive Vice President of Strategy and M&A, and Pawan Verma as Executive Vice President and …
Cencora Strengthens Leadership with Strategic Appointments Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has scheduled the release of its Fourth Quarter Fiscal 2024 results for Wednesday, November 6, 2024, before the market opens on the New York …
Cencora to Announce Fourth Quarter Fiscal 2024 Results Read More CONSHOHOCKEN, PA — Cencora, formerly known as AmerisourceBergen, is advancing pharmacy education with the introduction of two new initiatives aimed at deepening pharmacy residents’ understanding of the pharmacy supply chain and …
Cencora Launches Innovative Pharmacy Education Programs to Enhance Supply Chain Expertise Read More CONSHOHOCKEN, PA — Alcura, a part of Cencora, has received a Manufacturing and Importation Authorization (MIA) license for cell and gene therapies (CGT) from the Spanish Agency of Medicines and …
Alcura Secures MIA License to Enhance Cell and Gene Therapy Importation Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) reported a robust third quarter for fiscal year 2024, with revenue climbing 10.9% year-over-year to $74.2 billion. The company also raised its full-year …
Cencora Reports Stellar Q3 Results and Upbeat Guidance: A Healthcare Investment to Watch Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) will release its third-quarter fiscal 2024 results on Wednesday, July 31, before the stock market opens. The company plans to discuss the results …
Cencora to Announce Q3 Fiscal 2024 Results on July 31 Read More CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced a recent agreement to repurchase approximately $400 million of its common stock from Walgreens Boots Alliance Holdings LLC. This move is …
Cencora to Buy Back $400 Million in Shares from Walgreens Boots Alliance Read More CONSHOHOCKEN, PA — Backed by a strong quarter, healthcare giant Cencora Inc. (NYSE: COR) recently announced a salient 7.8% year-over-year revenue increase for the second quarter of the 2024 fiscal …
Cencora Inc. Posts Strong Second Quarter Performance, Raises Revenue Guidance for 2024 Fiscal Year Read More